<?xml version="1.0" encoding="UTF-8"?>
<p>Despite great progress Egypt's response is challenged by difficulties in capturing non‐responders to treatment and lack of appropriate medications to initiate retreatment. Moreover, children under 12 years old cannot be treated because the medications have not yet been approved for this age group. Finally, plans and strategies for surveillance to reliably capture whether hepatitis C elimination targets have been met are not fully developed.</p>
